Education
About Us
Working with TipRanks
Follow Us
Vitrafy Life Sciences Ltd. (AU:VFY)
ASX:VFY
VFY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$1.28 - AU$2.10
Previous CloseN/A
Volume59.93K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding63,849,674
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.15Price Target Upside58.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Vitrafy Life Sciences Ltd. News
PremiumCompany Announcements
Vitrafy Life Sciences to Present at NWR Virtual Healthcare Conference
PremiumCompany Announcements
Vitrafy Life Sciences Announces Director’s Share Acquisition
PremiumCompany Announcements
Vitrafy Secures $4.8 Million Grant for Cryopreservation Technology ExpansionPremiumCompany Announcements
Vitrafy Life Sciences Announces Cessation of Securities
PremiumCompany Announcements
Vitrafy Life Sciences Ltd. Unveils Half-Year FY2025 Financial Results
PremiumCompany Announcements
Vitrafy Life Sciences Reports Revenue Growth but Faces Increased Losses
PremiumCompany Announcements
Vitrafy Life Sciences to Announce FY2025 Half-Year ResultsPremiumCompany Announcements
Vitrafy Life Sciences Releases Restricted Securities from Escrow---
Options Prices
Currently, No data available
---
Ownership Overview
3.01% Insiders
―
Mutual Funds
― Other Institutional Investors
96.99% Public Companies and
Individual Investors
VFY FAQ
What was Vitrafy Life Sciences Ltd.’s price range in the past 12 months?
Vitrafy Life Sciences Ltd. lowest share price was AU$1.27 and its highest was AU$2.10 in the past 12 months.
What is Vitrafy Life Sciences Ltd.’s market cap?
Currently, no data Available
When is Vitrafy Life Sciences Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vitrafy Life Sciences Ltd.’s earnings last quarter?
Vitrafy Life Sciences Ltd. released its earnings results on Feb 06, 2025. The company reported -AU$0.986 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.986.
Is Vitrafy Life Sciences Ltd. overvalued?
According to Wall Street analysts Vitrafy Life Sciences Ltd.’s price is currently Undervalued.
Does Vitrafy Life Sciences Ltd. pay dividends?
Vitrafy Life Sciences Ltd. does not currently pay dividends.
What is Vitrafy Life Sciences Ltd.’s EPS estimate?
Vitrafy Life Sciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vitrafy Life Sciences Ltd. have?
Vitrafy Life Sciences Ltd. has 63,849,674 shares outstanding.
What happened to Vitrafy Life Sciences Ltd.’s price movement after its last earnings report?
Vitrafy Life Sciences Ltd. reported an EPS of -AU$0.986 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.748%.
Which hedge fund is a major shareholder of Vitrafy Life Sciences Ltd.?
Currently, no hedge funds are holding shares in AU:VFY
---
Vitrafy Life Sciences Ltd. Stock Smart Score
VFY Stock 12 Month Forecast
Average Price Target
AU$2.15
▲(58.09% Upside)
Technical Analysis
CSL
―
Resonance Health Ltd
―
Race Oncology Ltd.
―
Cyclopharm Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Best Analysts Covering VFY
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-7.40%
reiterated a buy rating last month
Copying Tom Godfrey's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -7.40% per trade.
---